Cargando…

Methodological Considerations in Estimating Adherence and Persistence for a Long-Acting Injectable Medication

BACKGROUND: Measures of medication adherence and persistence are important for researchers and policymakers to assess quality of care. Lack of adherence has been associated with adverse outcomes and higher costs of care. Long-acting medication formulations, including injectable forms, have been prop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Campagna, Elizabeth J., Muser, Erik, Parks, Joseph, Morrato, Elaine H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2014
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437404/ https://www.ncbi.nlm.nih.gov/pubmed/24967528 http://dx.doi.org/10.18553/jmcp.2014.20.7.756

Ejemplares similares

Evaluation of adherence and persistence with oral versus long-acting injectable antipsychotics in patients with early psychosis
por: Titus-Lay, Erika N., et al.
Publicado: (2018)

Advancing regulatory science and assessment of FDA REMS programs: A mixed-methods evaluation examining physician survey response
por: Brewer, Sarah E., et al.
Publicado: (2019)

Injectable Long-Acting Cabotegravir–Rilpivirine Therapy for People Living With HIV/AIDS: Addressing Implementation Barriers From the Start
por: Pinto, Rogério M., et al.
Publicado: (2023)

Long-acting injectable risperidone in partially adherent and nonadherent patients with schizophrenia
por: Louzã, Mário Rodrigues, et al.
Publicado: (2011)

Management of Persistent Hyponatremia Induced by Long-acting Injectable Risperidone Therapy
por: Chowdhury, Waliul, et al.
Publicado: (2018)

Low Adherence Achieves High HCV Cure Rates Among People Who Inject Drugs Treated With Direct-Acting Antiviral Agents
por: Norton, Brianna L, et al.
Publicado: (2020)

Methodological considerations for estimating policy effects in the context of co-occurring policies
por: Griffin, Beth Ann, et al.
Publicado: (2022)

2563 National dissemination of the accrual to clinical trials (ACT) network across the Clinical and Translational Science Award (CTSA) Consortium*
por: Morrato, Elaine H., et al.
Publicado: (2018)

Adjusting for geographic variation in observational comparative effectiveness studies: a case study of antipsychotics using state Medicaid data
por: Root, Elisabeth Dowling, et al.
Publicado: (2014)

Consideration of Long-Acting Injectable Antipsychotics for Polypharmacy Regimen in the Treatment of Schizophrenia: Put It on the Table or Not?
por: Pae, Chi-Un, et al.
Publicado: (2021)

Long-Acting Injectable Drugs for HIV-1 Pre-Exposure Prophylaxis: Considerations for Africa
por: Moyo, Enos, et al.
Publicado: (2022)

Accrual to Clinical Trials (ACT): A Clinical and Translational Science Award Consortium Network
por: Visweswaran, Shyam, et al.
Publicado: (2018)

Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillation
por: Paquette, Miney, et al.
Publicado: (2020)

Are Patients and Their Providers Talking About Long-Acting Injectable Antiretroviral Therapy? Penetration into Clinical Encounters at Three U.S. Care Sites
por: Christopoulos, Katerina A, et al.
Publicado: (2022)

Treatment Adherence with Early Prescription of Long-Acting Injectable Antipsychotics in Recent-Onset Schizophrenia
por: Viala, Annie, et al.
Publicado: (2012)

Adderall-Induced Persistent Psychotic Disorder Managed With Long-Acting Injectable Haloperidol Decanoate
por: Desai, Saral, et al.
Publicado: (2022)

Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy
por: Benning, Lorie, et al.
Publicado: (2020)

Concurrent application of TMS and near-infrared optical imaging: methodological considerations and potential artifacts
por: Parks, Nathan A.
Publicado: (2013)

A customized adherence enhancement program combined with long-acting injectable antipsychotic medication (CAE-L) for poorly adherent patients with chronic psychotic disorder in Tanzania: A pilot study methodological report
por: Mbwambo, Jessie, et al.
Publicado: (2019)

Impact of long-acting injectable antipsychotics on medication adherence and clinical, functional, and economic outcomes of schizophrenia
por: Kaplan, Gabriel, et al.
Publicado: (2013)

Methodological considerations of investigating adherence to using offloading devices among people with diabetes
por: Jarl, Gustav
Publicado: (2018)

Estimating incidence of venous thromboembolism in COVID‐19: Methodological considerations
por: Nab, Linda, et al.
Publicado: (2022)

The negative footprint illusion in environmental impact estimates: Methodological considerations
por: Sörqvist, Patrik, et al.
Publicado: (2022)

Treatment adherence and persistence with long-acting somatostatin analog therapy for the treatment of acromegaly: a retrospective analysis
por: Gurel, Michelle H., et al.
Publicado: (2017)

Effects of particulate air pollution on tuberculosis development in seven major cities of Korea from 2010 to 2016: methodological considerations involving long-term exposure and time lag
por: Kim, Honghyok, et al.
Publicado: (2020)

Incidence and Impact of Persistent Viremia on SVR Rates in Patients Receiving Direct-Acting Antiviral Therapy
por: Carver, Alicia B, et al.
Publicado: (2020)

Persistent endotheliopathy in the pathogenesis of long COVID syndrome
por: Fogarty, Helen, et al.
Publicado: (2021)

Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
por: Bakshi, Rahul P., et al.
Publicado: (2018)

Inpatient prescribing patterns of long-acting injectables and their oral or short-acting injectable equivalent formulations
por: Liu, Yifei, et al.
Publicado: (2023)

Patient and Health Care Provider Perspectives on Long Acting Injectable Antipsychotics in Schizophrenia and the Introduction of Olanzapine Long-Acting Injection
por: Wehring, Heidi J., et al.
Publicado: (2011)

1029. Long-Term Patient Adherence and Management of Treatment Interruptions With Long-Acting Injectable Cabotegravir + Rilpivirine for Maintenance Therapy in Phase IIb/III Studies
por: Teichner, Paula, et al.
Publicado: (2020)

Effectiveness and Tolerability of Switching to Aripiprazole Once Monthly from Antipsychotic Polypharmacy and/or Other Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study
por: Pae, Chi-Un, et al.
Publicado: (2020)

Multiple Sclerosis Patients Treated With Diroximel Fumarate in the Real-World Setting Have High Rates of Persistence and Adherence
por: Liseno, Jacob, et al.
Publicado: (2021)

Medication adherence in patients with psychotic disorders: an observational survey involving patients before they switch to long-acting injectable risperidone
por: Baylé, Franck Jean, et al.
Publicado: (2015)

Evaluation of adherence in patients prescribed long-acting injectable antipsychotics: A comparison of biweekly versus monthly administered neuroleptics
por: Carr, Chelsea N., et al.
Publicado: (2016)

The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
por: Miyamoto, Seiya, et al.
Publicado: (2017)

Inspirational chemistry of bioabsorbable long-acting injectables
por: Tice, Thomas
Publicado: (2022)

884. Patient Adherence to Long-Acting Injectable Cabotegravir + Rilpivirine Through 48 Weeks of Maintenance Therapy in the Phase 3 ATLAS and FLAIR Studies
por: Teichner, Paula, et al.
Publicado: (2019)

The importance of adherence and persistence in the elderly atrial fibrillation patient
por: Hylek, Elaine M
Publicado: (2020)

Long COVID in the Long Run—23-Month Follow-up Study of Persistent Symptoms
por: Helmsdal, Gunnhild, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i4c1toecf4mhq56d1fgnf0b8ui